Horizon Acquisition Corp. (NYSE:HZAC) secured shareholder approval of its combination with ticket marketplace Vivid Seats in a meeting held yesterday.
Approximately 95.5% of the votes cast at yesterday’s special meeting were in favor of the business combination.
Today’s press release did not disclose redemption amounts, but HZAC reached a 52-week high of $11.78 yesterday and closed the day with a 9.30% gain at $11.28.
Just yesterday, HZAC announced that it swapped out a portion of its PIPE financing with Vivid Seats, replacing an allotment set to be purchased by its affiliate Eldridge Industries with commitments from DraftKings (NASDAQ:DKNG). Since the investment was announced so late, it will not have any impact on redemptions as that deadline passed on October 10 and the change did not actually bring in additional funding to the deal.
The business combination is expected to close on Monday, October 18, and the common stock and warrants of Vivid Seats are expected to begin trading on the Nasdaq Global Market under the symbols “SEAT” and “SEATW,” respectively, on Tuesday, October 19.
Horizon originally announced its $2.059 billion combination with Vivid on April 22. Chicago-based Vivid provides a marketplace for the $39 billion concert, theatre and sporting event ticket market.
Horizon also announced today that its public warrant holders voted to approve its proposed warrant agreement amendment, which received approximately 99.9% approval.
ADVISORS
- Evercore is acting as exclusive financial and capital advisor to Vivid Seats.
- Latham & Watkins LLP is acting as legal advisor to Vivid Seats.
- Credit Suisse is acting as lead financial and capital markets advisor to Horizon.
- Deutsche Bank Securities and RBC Capital Markets are also acting as financial and capital markets advisors to Horizon.
- Kirkland & Ellis LLP is acting as legal advisor to Horizon.
- Credit Suisse and Evercore acted as co-placement agents on the private offering.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...